Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,012 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A. Farmer H, et al. Among authors: johnson da. Nature. 2005 Apr 14;434(7035):917-21. doi: 10.1038/nature03445. Nature. 2005. PMID: 15829967
FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.
Sharpe R, Pearson A, Herrera-Abreu MT, Johnson D, Mackay A, Welti JC, Natrajan R, Reynolds AR, Reis-Filho JS, Ashworth A, Turner NC. Sharpe R, et al. Among authors: johnson d. Clin Cancer Res. 2011 Aug 15;17(16):5275-86. doi: 10.1158/1078-0432.CCR-10-2727. Epub 2011 Jun 28. Clin Cancer Res. 2011. PMID: 21712446 Free PMC article.
Early gene signalling-dependent and -independent induction of apoptosis in Ramos human B cells can be inhibited by over-expression of Bcl-2.
Ning ZQ, Norton JD, Johnson D, Murphy JJ. Ning ZQ, et al. Among authors: johnson d. Biochem Biophys Res Commun. 1995 Oct 4;215(1):23-9. doi: 10.1006/bbrc.1995.2429. Biochem Biophys Res Commun. 1995. PMID: 7575596
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
Wienke D, Davies GC, Johnson DA, Sturge J, Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D, Reis-Filho JS, Isacke CM. Wienke D, et al. Among authors: johnson da. Cancer Res. 2007 Nov 1;67(21):10230-40. doi: 10.1158/0008-5472.CAN-06-3496. Cancer Res. 2007. PMID: 17974964
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.
Murugaesu N, Iravani M, van Weverwijk A, Ivetic A, Johnson DA, Antonopoulos A, Fearns A, Jamal-Hanjani M, Sims D, Fenwick K, Mitsopoulos C, Gao Q, Orr N, Zvelebil M, Haslam SM, Dell A, Yarwood H, Lord CJ, Ashworth A, Isacke CM. Murugaesu N, et al. Among authors: johnson da. Cancer Discov. 2014 Mar;4(3):304-17. doi: 10.1158/2159-8290.CD-13-0287. Epub 2014 Feb 11. Cancer Discov. 2014. PMID: 24520024
Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene.
Rao RN, Stamm NB, Otto K, Kovacevic S, Watkins SA, Rutherford P, Lemke S, Cocke K, Beckmann RP, Houck K, Johnson D, Skidmore BJ. Rao RN, et al. Among authors: johnson d. Oncogene. 1999 Nov 4;18(46):6343-56. doi: 10.1038/sj.onc.1203009. Oncogene. 1999. PMID: 10597234
Regulation of both apoptosis and cell survival by the v-Src oncoprotein.
Johnson D, Agochiya M, Samejima K, Earnshaw W, Frame M, Wyke J. Johnson D, et al. Cell Death Differ. 2000 Aug;7(8):685-96. doi: 10.1038/sj.cdd.4400700. Cell Death Differ. 2000. PMID: 10918442
Advocacy, Strategy and Tactics Used to Confront Corporate Power: The Nestlé Boycott and International Code of Marketing of Breast-milk Substitutes.
Johnson DA, Duckett LJ. Johnson DA, et al. J Hum Lact. 2020 Oct 9:890334420955158. doi: 10.1177/0890334420955158. Online ahead of print. J Hum Lact. 2020. PMID: 33035127
Confronting Corporate Power : Strategies and Phases of the Nestle Boycott.
Johnson DA. Johnson DA. J Hum Lact. 2020 Oct 9:890334420964752. doi: 10.1177/0890334420964752. Online ahead of print. J Hum Lact. 2020. PMID: 33035126 No abstract available.
Disparities in Sleep Health and Potential Intervention Models: A Focused Review.
Billings ME, Cohen RT, Baldwin CM, Johnson DA, Palen BN, Parthasarathy S, Patel SR, Russell M, Tapia IE, Williamson AA, Sharma S. Billings ME, et al. Among authors: johnson da. Chest. 2020 Sep 29:S0012-3692(20)34840-6. doi: 10.1016/j.chest.2020.09.249. Online ahead of print. Chest. 2020. PMID: 33007324 Free PMC article. Review.
1,012 results
Jump to page